Increase in ALK1/ALK5 Ratio as a Cause for Elevated MMP-13 Expression in Osteoarthritis in Humans and Mice

E.N. Blaney Davidson(Radboud University Nijmegen), P.M. van der Kraan(Radboud University Nijmegen)

The Journal of Immunology

June 1, 2009

10.4049/jimmunol.0803991

Cited by 315

Related Papers

Prophylactic treatment with S100A9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritis

|Annals of the Rheumatic Diseases|2015|93

Activin Receptor-Like Kinase Receptors ALK5 and ALK1 Are Both Required for TGFβ-Induced Chondrogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells

|PLoS ONE|2015|40

Wnts talking with the TGF-β superfamily: WISPers about modulation of osteoarthritis

|Lara D. Veeken|2015|32

Identification of Transcription Factors Responsible for a Transforming Growth Factor-β-Driven Hypertrophy-like Phenotype in Human Osteoarthritic Chondrocytes

|Cells|2022|16